These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12841828)

  • 1. Melatonin for the treatment of tardive dyskinesia.
    Nelson LA; McGuire JM; Hausafus SN
    Ann Pharmacother; 2003; 37(7-8):1128-31. PubMed ID: 12841828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E in the treatment of tardive dyskinesia.
    Boomershine KH; Shelton PS; Boomershine JE
    Ann Pharmacother; 1999 Nov; 33(11):1195-202. PubMed ID: 10573320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pineal calcification and subtypes of tardive dyskinesia.
    Sandyk R
    Int J Neurosci; 1990 Aug; 53(2-4):223-9. PubMed ID: 1979971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is melatonin treatment effective for tardive dyskinesia?
    Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
    J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia.
    Soares-Weiser K; Fernandez HH
    Semin Neurol; 2007 Apr; 27(2):159-69. PubMed ID: 17390261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia in bipolar disorders: possible role of pineal melatonin.
    Sandyk R
    Int J Neurosci; 1990 Jun; 52(3-4):233-8. PubMed ID: 2269610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome.
    Sandyk R; Kay SR
    Int J Neurosci; 1991 Jun; 58(3-4):215-47. PubMed ID: 1365044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
    Shamir E; Barak Y; Shalman I; Laudon M; Zisapel N; Tarrasch R; Elizur A; Weizman R
    Arch Gen Psychiatry; 2001 Nov; 58(11):1049-52. PubMed ID: 11695951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of melatonin in tardive dyskinesia.
    Castro F; Carrizo E; Prieto de Rincón D; Rincón CA; Asián T; Medina-Leendertz S; Bonilla E
    Invest Clin; 2011 Sep; 52(3):252-60. PubMed ID: 21950196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia associated with depression in a bipolar patient: possible role of melatonin.
    Sandyk R
    Int J Neurosci; 1990 May; 52(1-2):79-83. PubMed ID: 1979969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
    Peritogiannis V; Tsouli S
    J Psychopharmacol; 2010 Jul; 24(7):1121-5. PubMed ID: 19395427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies.
    Macaluso M; Flynn A; Preskorn S
    J Psychiatr Pract; 2016 Jan; 22(1):42-9. PubMed ID: 26813487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
    Lerner V; Kaptsan A; Miodownik C; Kotler M
    Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genetic variations in the human melatonin receptor (MTNR1A, MTNR1B) genes and antipsychotics-induced tardive dyskinesia in schizophrenia.
    Lai IC; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
    World J Biol Psychiatry; 2011 Mar; 12(2):143-8. PubMed ID: 20726823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia: a review and current treatment options.
    Najib J
    Am J Ther; 1999 Jan; 6(1):51-60. PubMed ID: 10423647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia.
    Browne J; Silver H; Martin R; Hart R; Mergener M; Williams P
    J Clin Psychopharmacol; 1986 Apr; 6(2):88-92. PubMed ID: 2871058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral-paliperidone-induced tardive dyskinesia: a case report.
    Wei HT; Lai YW; Chen MH; Chen YS
    Gen Hosp Psychiatry; 2012; 34(5):578.e5-6. PubMed ID: 22154659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia: review of treatments past, present, and future.
    Gupta S; Mosnik D; Black DW; Berry S; Masand PS
    Ann Clin Psychiatry; 1999 Dec; 11(4):257-66. PubMed ID: 10596740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
    Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R; Annable L
    Can J Psychiatry; 2005 Oct; 50(11):703-14. PubMed ID: 16363464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.